ABBV (abbvie.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan AbbVie Inc (ABBV)

Strict FDA standards and patent protection guarantee the reliability of AbbVie Inc. (ABBV). The company's market-to-book ratio on this GURU.Markets chart confirms this, with the indicator settling at -85.90. A strong R&D pipeline and immunology experts ensure resilience, while strategic marketing focused on extending drug patents creates a foundation for stable profit growth.

ABBV AbbVie Corp.: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar AbbVie Inc (ABBV)

- rega lan prakiraan konsensus rega:
Kutipan saham AbbVie Inc.|ABBV - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Abbvie|ABBV - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham AbbVie|ABBV - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku abbvie.com|ABBV - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas AbbVie Inc.|ABBV - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Abbvie|ABBV - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Abbvie|ABBV - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan AbbVie
Analisis wiwitan perusahaan:AbbVie Inc. - ABBV
Produk asli Abbvie

This indicator determines the market-to-book ratio, reflecting the premium or discount of assets relative to their book value. By analyzing changes in the price-to-book multiple, an investor assesses the margin of safety for AbbVie Inc., where stable demand for innovative therapeutic lines and an expanding patient base minimize the risk of asset impairment during market downturns.

Pesaing utama

Eli Lilly and Company (LLY) - Rasio Kapitalisasi marang Aset Bersih|AZN (astrazeneca.com) - Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Novartis NVS|Kapitalisasi Pasar marang Aset Bersih Merck & Co.|Novo Nordisk Inc. (NVO) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Amgen Inc (AMGN)|Rasio Kapitalisasi Pasar marang Nilai Buku PFE (Pfizer Inc.)|sanofi.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Bristol Myers Squibb (BMY)|GSK: Nilai Pasar marang Nilai Buku|TAK (Takeda Pharmaceutical Company Limited) - Rasio Nilai Pasar marang Nilai Buku|Teva Pharmaceuticals (TEVA) - Rasio Kapitalisasi marang Aset Bersih|RDY (Dr. Reddy's Laboratories) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku viatris.com (VTRS)|Roivant Sciences (ROIV) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku Zai Lab Ltd (ZLAB)|Rasio Kapitalisasi Pasar marang Nilai Buku Valeant Pharmaceuticals|Cosmos Health Inc - Nilai Pasar marang Nilai Buku